Managing repeat transplant failureWhen considering the Boston type 1 keratoprosthesis as the evidence-based procedure of choice for managing cornea graft failure, superior visual outcomes must be weighed against greater risk of sight-threatening complications.
Frozen, fresh corneal donor carriers yield similar clinical outcomesFive-year results from a study of the Boston keratoprosthesis type 1 implant suggest that frozen and fresh corneal donors offer similar clinical outcomes—with no significant differences in device retention, visual rehabilitation or complication rates.